Workshop C – Leveraging Synthetic DNA for Faster, Scalable & Cost-Effective Solutions to Meet Scaling Manufacturing Demands
Time: 2:30 pm
day: Pre-Conference Workshop Day
Details:
Synthetic DNA presents a game-changing opportunity to address challenges inherent to pDNA—such as endotoxicity, immunogenicity, and long production timelines. While it has yet to achieve widespread adoption, the time is ripe to harness its potential and revolutionise mRNA manufacturing processes. This workshop will explore how synthetic DNA can drive efficiency, scalability, and customisation in mRNA production, empowering manufacturers to meet diverse therapeutic and vaccine demands.
- How can synthetic DNA protocols be optimised to minimise error rates and reduce raw material costs while achieving yield targets with up to 50% less DNA input?
- How can synthetic DNA templates accelerate manufacturing timelines, from 9 weeks to 1 week, for continuous manufacturing and enhanced readiness for largescale and personalised demands?
- How do tailored synthetic platforms create opportunities for custom mRNA production, enabling rapid adaptation for diverse therapeutic and vaccine needs?
- What are the key barriers to adopting synthetic DNA, and how can they be overcome to accelerate mainstream implementation in mRNA manufacturing?
